RxDoctor Payments Data

Aaron Gipsman, MD

Sports Medicine · Pasadena, CANPI 1669854923

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (45.4%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Arthrex at 51.6% of the total. Reporting peaked in 2020 at $27,875 and has fallen 92.8% since, to $1,996 in 2025.

$48,458in general payments, 2019–2025

Across 88 payments — averaging $550.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$25K
  • Smith+Nephew$20K
  • Gotham Surgical Solutions & Devices, Inc.$2K
  • Stryker$560
  • Zimmer Biomet$192
  • Globus Medical$184
  • plus $600 from 15 others
$10,572in ownership & investment interests, 2019–2025

Across 4 payments — averaging $2643.00 each. An ownership or investment interest held by the physician or an immediate family member.

  • Lazurite Inc.$11K

What the payments were for

  • Grants$20,00041%
  • Travel & lodging$3,2857%
  • Food & beverage$3,1777%
  • Education$21,99645%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,458 in reported general payments places this provider in the 85th percentile of 662 sports medicine providers in California.

See all sports medicine providers in California →

Medicare billing

Part B allowed, 2024
$27,650
Medicare patients
64
Services billed
384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib49$655
Diclofenac Sodium11$631
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$156
Naproxen13$77
Meloxicam33$23

Paid to pharmacies, not to this prescriber.

Other sports medicine in Pasadena

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →